Objectives Prediction of long term clinical outcome in patients with primary progressive multiple sclerosis (PPMS) using imaging has important clinical implications, but remains challenging. We aimed ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Multiple sclerosis is assumed to be a rare condition in our country, but it is probably undiagnosed and almost certainly misdiagnosed at the early stages.

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

Although there is currently no cure for multiple sclerosis, it’s not a fatal condition. Here’s what you need to know about MS and life expectancy.

There’s no cure for multiple sclerosis, but treatment can help slow the disease progression and reduce symptoms. Learn about these treatments and more.

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances.

Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.

In multiple sclerosis, the ability of clinicians to provide a prognosis for a patient and the design and interpretation of clinical trials both rely heavily on prognostic factors identified from ...